Air Products & Chemicals
APD
297.09
-6.74
-2.22%
Air Products & Chemicals
US · APD
#351 by market cap
Listed 1970
297.09
-6.74
-2.22%
Periodic snapshot; not a real-time feed.
· 2026-11-20 16:38
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 01:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-K | 2026-11-19 | Read on SEC.gov |
| 8-K | 2026-11-18 | Read on SEC.gov |
| 8-K | 2026-11-05 | Read on SEC.gov |
| 10-Q | 2026-07-30 | Read on SEC.gov |
| 8-K | 2026-07-30 | Read on SEC.gov |
| 8-K | 2026-06-30 | Read on SEC.gov |
| 10-Q | 2026-04-30 | Read on SEC.gov |
| 8-K | 2026-04-30 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-21 16:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $12.99B | Annual | 2026-09-30 | 2026-11-19 | 10-K |
| Net income | $532.10M | Annual | 2026-09-30 | 2026-11-19 | 10-K |
| Operating cash flow | $4.68B | Annual | 2026-09-30 | 2026-11-19 | 10-K |
| Total assets | $41.21B | As of | 2026-09-30 | 2026-11-19 | 10-K |
| Total liabilities | $24.06B | As of | 2026-09-30 | 2026-11-19 | 10-K |
| Stockholders’ equity | $14.28B | As of | 2026-09-30 | 2026-11-19 | 10-K |
| Cash and cash equivalents | $1.33B | As of | 2026-09-30 | 2026-11-19 | 10-K |
Revenue annual, last 8 years
Latest year +7.92% YoY
Margins
- Gross margin
- 31.58%
- Operating margin
- 24.44%
- Net margin
- 4.10%
Key ratios & quality
- Enterprise valuei
- 82.61B
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.92B | 8.86B | 10.32B | 12.70B | 12.60B | 12.10B | 12.04B | 12.99B |
| Gross profit | 2.94B | 3.00B | 3.14B | 3.36B | 3.77B | 3.93B | 3.78B | 4.10B |
| Selling & admin expenses | 750.00M | 742.10M | 828.40M | 900.60M | 957.00M | 942.40M | 906.10M | 903.20M |
| Research & development | 72.90M | 83.90M | 93.50M | 102.90M | 105.60M | 100.20M | 96.30M | 88.90M |
| Operating profit | 2.17B | 2.24B | 2.27B | 2.41B | 2.74B | 2.95B | 2.89B | 3.18B |
| Pretax profit | 2.29B | 2.42B | 2.51B | 2.75B | 2.88B | 4.82B | -440.70M | 552.00M |
| Tax | 480.10M | 478.40M | 462.80M | 500.80M | 551.20M | 944.90M | -94.30M | 1.60M |
| Net profit | 1.81B | 1.93B | 2.11B | 2.27B | 2.34B | 3.86B | -354.40M | 550.40M |
| Basic EPS | 8 | 9 | 9 | 10 | 10 | 17 | -2 | 2 |
| Diluted EPS | 7.94 | 8.49 | 9.43 | 10.14 | 10.33 | 17.18 | -1.77 | 2.39 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 3.02B | 3.17B | 3.10B | 3.17B | 3.16B | 3.56B |
| Gross profit | 982.60M | 1.02B | 995.00M | 987.40M | 1.04B | 1.08B |
| Selling & admin expenses | 222.60M | 219.10M | 228.70M | 227.20M | 219.10M | 228.20M |
| Research & development | 24.10M | 27.30M | 20.40M | 21.60M | 21.50M | 25.40M |
| Operating profit | 772.40M | 811.80M | 756.50M | 752.70M | 810.30M | 855.70M |
| Pretax profit | 890.80M | 121.30M | 850.80M | 883.50M | -1.94B | 755.40M |
| Tax | 159.60M | 111.20M | 159.40M | 158.70M | -515.40M | 198.90M |
| Net profit | 723.20M | 10.10M | 691.40M | 724.80M | -1.42B | 556.50M |
| Basic EPS | 3 | 0 | 3 | 3 | -6 | 3 |
| Diluted EPS | 3.20 | 0.02 | 3.04 | 3.19 | -6.47 | 2.62 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.62B | 8.68B | 8.38B | 6.28B | 5.20B | 6.36B | 5.83B | 5.02B |
| Cash & ST investments | 2.41B | 6.36B | 5.80B | 3.30B | 1.95B | 2.98B | 1.86B | 1.33B |
| Inventory | 388.30M | 404.80M | 453.90M | 514.20M | 651.80M | 766.00M | 776.50M | 741.20M |
| Total assets | 18.94B | 25.17B | 26.86B | 27.19B | 32.00B | 39.57B | 41.06B | 41.21B |
| Total current liabilities | 1.82B | 2.42B | 2.80B | 3.47B | 3.90B | 4.18B | 4.22B | 4.71B |
| Short-term debt | 98.60M | 548.40M | 565.50M | 649.00M | 969.20M | 795.20M | 842.80M | 998.70M |
| Long-term debt | 3.23B | 7.43B | 7.15B | 7.09B | 9.43B | 13.53B | 16.95B | 16.78B |
| Total liabilities | 7,554,500,000.00 | 12,725,400,000.00 | 12,771,200,000.00 | 13,490,200,000.00 | 16,342,200,000.00 | 20,900,900,000.00 | 23,709,700,000.00 | 24,059,000,000.00 |
| Total equity | 11.39B | 12.44B | 14.09B | 13.70B | 15.66B | 18.67B | 17.35B | 17.15B |
| Retained earnings | 14.14B | 14.88B | 15.68B | 16.52B | 17.29B | 19.55B | 17.56B | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 6.15B | 5.83B | 5.10B | 5.01B | 4.96B | 5.02B |
| Cash & ST investments | 2.32B | 1.86B | 1.03B | 951.00M | 980.50M | 1.33B |
| Inventory | 797.70M | 776.50M | 788.10M | 767.90M | 751.60M | 741.20M |
| Total assets | 41.66B | 41.06B | 41.24B | 41.64B | 40.45B | 41.21B |
| Total current liabilities | 4.76B | 4.22B | 3.50B | 3.51B | 4.58B | 4.71B |
| Short-term debt | 1.24B | 842.80M | 236.50M | 487.90M | 896.20M | 998.70M |
| Long-term debt | 16.46B | 16.95B | 17.30B | 17.27B | 16.77B | 16.78B |
| Total liabilities | 23,891,100,000.00 | 23,709,700,000.00 | 23,403,600,000.00 | 23,494,900,000.00 | 23,849,200,000.00 | 24,059,000,000.00 |
| Total equity | 17.77B | 17.35B | 17.84B | 18.15B | 16.60B | 17.15B |
| Retained earnings | 17.95B | 17.56B | 17.84B | 18.14B | 16.30B | -- |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.97B | 3.26B | 3.34B | 3.23B | 3.21B | 3.65B | 3.26B | 4.68B |
| Depreciation & amortization | 1.08B | 1.19B | 1.32B | 1.34B | 1.36B | 1.45B | 1.56B | 1.52B |
| Free cash flow | 980.20M | 755.70M | 877.70M | 303.70M | -1.42B | -3.15B | -3.77B | 476.80M |
| Dividends paid | -994.00M | -1.10B | -1.26B | -1.38B | -1.50B | -1.56B | -1.58B | -1.60B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 2.25B | 5.25B | 4.47B | 2.71B | 1.62B | 2.98B | 1.86B | 1.33B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 855.80M | 1.26B | 900.70M | 1.10B | 1.31B | 1.37B |
| Depreciation & amortization | 401.00M | 412.80M | 370.70M | 375.00M | 385.40M | 390.80M |
| Free cash flow | -640.00M | -256.50M | -350.50M | -3.90M | 309.50M | 521.70M |
| Dividends paid | -398.30M | -398.40M | -398.40M | -398.60M | -403.00M | -403.10M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 2.32B | 1.86B | 1.03B | 951.00M | 980.50M | 1.33B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.06 | 16.31 | 16.39 | 16.91 | 16.76 | 24.42 | -2.46 | 3.63 |
| ROA %i | 9.23 | 8.55 | 8.07 | 8.35 | 7.77 | 10.70 | -0.98 | 1.29 |
| ROIC %i | 12.86 | 11.36 | 10.51 | 10.92 | 10.44 | 13.95 | -0.69 | 2.28 |
| 5-year avg ROE %i | 18.32 | 18.09 | 19.60 | 16.00 | 16.49 | 18.16 | 14.40 | -- |
| EBIT margin %i | 27.21 | 28.60 | 25.66 | 22.70 | 24.28 | 41.65 | -1.88 | 5.95 |
| FCF / sales %i | 10.99 | 8.53 | 8.50 | 2.39 | -- | -- | -- | 3.67 |
| Current ratioi | 2.54 | 3.59 | 2.99 | 1.81 | 1.33 | 1.52 | 1.38 | 1.07 |
| Quick ratioi | 2.10 | 3.22 | 2.66 | 1.54 | 1.06 | 1.23 | 1.00 | 0.81 |
| Debt / assetsi | 17.56 | 33.03 | 30.60 | 30.62 | 34.47 | 37.92 | 44.83 | 44.24 |
| LT debt / equityi | 29.20 | 64.29 | 56.53 | 58.41 | 70.30 | 83.41 | 116.90 | 120.66 |
| Interest coveragei | 17.71 | 23.18 | 18.68 | 22.52 | 17.24 | 23.03 | -1.06 | 3.50 |
| Revenue CAGR (3Y) %i | 5.93 | 2.65 | 4.95 | 12.50 | 12.47 | 5.44 | -1.77 | 1.02 |
| Net income CAGR (3Y) %i | 40.76 | -14.33 | 11.91 | 8.63 | 6.83 | 22.18 | -- | -38.61 |
| FCF CAGR (3Y) %i | -17.62 | 13.09 | -3.14 | -32.33 | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 10.12 | -2.46 | -2.08 | 13.89 | -0.32 | 3.63 |
| ROA %i | 3.94 | -0.98 | -0.82 | 5.23 | -0.12 | 1.29 |
| ROIC %i | 5.38 | -0.69 | -0.47 | 7.02 | 0.26 | 2.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.72 | -1.88 | -1.27 | 23.90 | 1.10 | 5.95 |
| FCF / sales %i | -- | -- | -- | -- | -- | 3.67 |
| Current ratioi | 1.29 | 1.38 | 1.46 | 1.43 | 1.08 | 1.07 |
| Quick ratioi | 1.07 | 1.00 | 1.05 | 1.03 | 0.78 | 0.81 |
| Debt / assetsi | 44.03 | 44.83 | 43.98 | 44.08 | 44.89 | 44.24 |
| LT debt / equityi | 110.09 | 116.90 | 116.16 | 114.19 | 124.33 | 120.66 |
| Interest coveragei | 10.91 | -1.06 | -0.68 | 12.79 | 0.63 | 3.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 16:38:28 · For reference only, not investment advice and not tailored to your situation.
Air Products & Chemicals discussion 0 comments